The protein behind immunotherapy resistance

A study led by Professors Hanahan, Zeng, Saghafinia and Chryplewicz has uncovered a protein overexpressed in numerous cancer types that suppresses the effectiveness of immunotherapies. This discovery provides a basis for new therapeutic approaches.